Pu, Shenghong

Neuroimaging-aided differential diagnosis of the depressive state

Takizawa, R., Fukuda, M., Kawasaki, S., Kasai, K., Mimura, M., Pu, S., Noda, T., Niwa, S.-I., & Okazaki, Y. (2014) · NeuroImage

Optical Imaging and Spectroscopy TechniquesTreatment of Major Depression

Cited by 337

Beta-hydroxybutyrate, an endogenic NLRP3 inflammasome inhibitor, attenuates stress-induced behavioral and inflammatory responses

Yamanashi, T., Iwata, M., Kamiya, N., Tsunetomi, K., Kajitani, N., Wada, N., Iitsuka, T., Yamauchi, T., Miura, A., Pu, S., et al. (2017) · Scientific Reports

Tryptophan and brain disordersTreatment of Major Depression

Cited by 214

Reduced frontopolar activation during verbal fluency task associated with poor social functioning in late-onset major depression: Multi-channel near-infrared spectroscopy study

Pu, S., Matsumura, H., Yamada, T., Ikezawa, S., Mitani, H., Adachi, A., & Nakagome, K. (2008) · Psychiatry and Clinical Neurosciences

Optical Imaging and Spectroscopy TechniquesTreatment of Major Depression

Cited by 112

Empirical evidence for discrete neurocognitive subgroups in patients with non-psychotic major depressive disorder: clinical implications

Pu, S., Noda, T., Setoyama, S., & Nakagome, K. (2018) · Psychological Medicine

Treatment of Major DepressionSchizophrenia research and treatment

Cited by 60

Prefrontal cortex infusion of beta-hydroxybutyrate, an endogenous NLRP3 inflammasome inhibitor, produces antidepressant-like effects in a rodent model of depression

Kajitani, N., Iwata, M., Miura, A., Tsunetomi, K., Yamanashi, T., Matsuo, R., Nishiguchi, T., Fukuda, S., Nagata, M., Shibushita, M., et al. (2020) · Neuropsychopharmacology Reports

Tryptophan and brain disordersTreatment of Major Depression

Cited by 49